Clinical trial
Open-label, Randomized, 4-way Crossover, Monocentric, Controlled Study to Evaluate the Effect on Nitrogen Retention of Two Different Posology Schemes of PKU GOLIKE PLUS 3-16 and Free AAs in Patients With Phenylketonuria
NCT05229549 is registered in ClinicalTrials.gov with APR Applied Pharma Research s.a. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Open-label, Randomized, 4-way Crossover, Monocentric, Controlled Study to Evaluate the Effect on Nitrogen Retention of Two Different Posology Schemes of PKU GOLIKE PLUS 3-16 and Free AAs in Patients With Phenylketonuria
- Lead sponsor
- APR Applied Pharma Research s.a.
- Phase
- Not applicable
- Overall status
- Terminated
- Start date
- May 6, 2022
- Completion date
- February 7, 2023
- Enrollment
- 5 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.